Login to Your Account

RXi Splits; Galena Biopharma Keeps the Cancer Portfolio

By Marie Powers

Tuesday, September 27, 2011
Four years after splitting from Los Angeles-based CytRx Corp., RXi Pharmaceuticals Corp. is splitting again – this time, into two publicly traded companies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription